nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series
|
Riedel, Andreas |
|
|
8 |
6 |
p. 1504-1508 |
artikel |
2 |
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
|
Gurnari, Carmelo |
|
|
8 |
6 |
p. 1444-1448 |
artikel |
3 |
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
|
Metheny, Leland L. |
|
|
8 |
6 |
p. 1384-1391 |
artikel |
4 |
A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial
|
Carcao, Manuel |
|
|
8 |
6 |
p. 1494-1503 |
artikel |
5 |
Campbell BA, Dobos G, Haider Z, et al. International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies. Blood Adv. 2023;7(21):6639-6647.
|
|
|
|
8 |
6 |
p. 1469 |
artikel |
6 |
CEBPA double mutations associated with ABO antigen weakness in hematologic diseases
|
Choi, Seung Jun |
|
|
8 |
6 |
p. 1487-1493 |
artikel |
7 |
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma
|
Nie, Esther H. |
|
|
8 |
6 |
p. 1474-1486 |
artikel |
8 |
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
|
Mohsenian, Samin |
|
|
8 |
6 |
p. 1392-1404 |
artikel |
9 |
Coping in patients with hematologic malignancies undergoing hematopoietic cell transplantation
|
Newcomb, Richard |
|
|
8 |
6 |
p. 1369-1378 |
artikel |
10 |
Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score
|
Okada, Yosuke |
|
|
8 |
6 |
p. 1359-1368 |
artikel |
11 |
Fine and Gray or Cox model?
|
Arcuri, Leonardo Javier |
|
|
8 |
6 |
p. 1420-1421 |
artikel |
12 |
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
|
Conconi, Annarita |
|
|
8 |
6 |
p. 1541-1549 |
artikel |
13 |
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma
|
Rutherford, Sarah C. |
|
|
8 |
6 |
p. 1464-1468 |
artikel |
14 |
Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?
|
Huibers, Minke |
|
|
8 |
6 |
p. 1509-1514 |
artikel |
15 |
Liver abnormalities are frequent and persistent in patients with Fanconi anemia
|
Snyder, Alana J. |
|
|
8 |
6 |
p. 1427-1438 |
artikel |
16 |
Longitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS
|
Flora, Christopher |
|
|
8 |
6 |
p. 1422-1426 |
artikel |
17 |
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study
|
Mitani, Kinuko |
|
|
8 |
6 |
p. 1415-1419 |
artikel |
18 |
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells
|
Pavani, Giulia |
|
|
8 |
6 |
p. 1449-1463 |
artikel |
19 |
Navigating the prognostic role of transfusions after CAR-T
|
Alhomoud, Mohammad |
|
|
8 |
6 |
p. 1570-1572 |
artikel |
20 |
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
|
Yacoub, Abdulraheem |
|
|
8 |
6 |
p. 1515-1528 |
artikel |
21 |
Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential
|
Wurtzel, Jeremy G. T. |
|
|
8 |
6 |
p. 1550-1566 |
artikel |
22 |
Platelets, plasma, and proteostasis: a translation tightrope
|
Portier, Irina |
|
|
8 |
6 |
p. 1567-1569 |
artikel |
23 |
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
|
Mazzucconi, Maria Gabriella |
|
|
8 |
6 |
p. 1529-1540 |
artikel |
24 |
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells
|
Watanabe, Tatsuro |
|
|
8 |
6 |
p. 1345-1358 |
artikel |
25 |
Self-reported pain levels for emergency department visits associated with sickle cell disease in the United States
|
Attell, Brandon K. |
|
|
8 |
6 |
p. 1470-1473 |
artikel |
26 |
Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization
|
Cancilla, Daniel |
|
|
8 |
6 |
p. 1379-1383 |
artikel |
27 |
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)
|
Vic, Samuel |
|
|
8 |
6 |
p. 1573-1585 |
artikel |
28 |
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
|
Lew, Thomas E. |
|
|
8 |
6 |
p. 1439-1443 |
artikel |
29 |
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
|
Sidonio Jr., Robert F. |
|
|
8 |
6 |
p. 1405-1414 |
artikel |